An Observational Study to Describe Women Exposed to Apremilast During Pregnancy and Infant Outcomes During the First Year of Life (20210218)

First published 06/12/2023

Last updated 12/05/2025

EU PAS number:

EUPAS107685

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Protocol-Published Original apremilast 20210218 .pdf

English (875.11 KB - PDF)View document

Study results

Study results

20210218_ORSR Abstract_21APR2025_Redacted.pdf

English (904.44 KB - PDF)View document

Study report

Other information